CDK8 and neoplasm: We also measured the effect of Senexin B on the number of circulating tumor cells (CTC) in mouse blood, an early indicator of metastatic spread, and found that the CTC number was strongly reduced by the CDK8/19i (SI Appendix, Fig. S3 C and D).